S1034 Insurance Policy Changes

HCPCS S1034 is officially defined as "Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices." HCPCS S1034 is referenced in 3 tracked payer policy changes from UnitedHealthcare and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S1034 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.